Electromed (NYSE:ELMD – Get Free Report) and Jushi (OTCMKTS:JUSHF – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, dividends, valuation and earnings.
Profitability
This table compares Electromed and Jushi’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Electromed | 11.34% | 15.71% | 13.37% |
| Jushi | -19.98% | N/A | -12.91% |
Risk and Volatility
Electromed has a beta of 0.43, indicating that its stock price is 57% less volatile than the S&P 500. Comparatively, Jushi has a beta of -0.61, indicating that its stock price is 161% less volatile than the S&P 500.
Institutional & Insider Ownership
40.8% of Electromed shares are held by institutional investors. Comparatively, 21.7% of Jushi shares are held by institutional investors. 11.0% of Electromed shares are held by insiders. Comparatively, 23.1% of Jushi shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Earnings and Valuation
This table compares Electromed and Jushi”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Electromed | $75.57 million | 2.60 | $5.15 million | $1.38 | 17.18 |
| Jushi | $262.91 million | 0.32 | -$68.59 million | ($0.28) | -1.48 |
Electromed has higher earnings, but lower revenue than Jushi. Jushi is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a breakdown of recent recommendations for Electromed and Jushi, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Electromed | 0 | 1 | 3 | 0 | 2.75 |
| Jushi | 0 | 0 | 1 | 0 | 3.00 |
Electromed presently has a consensus target price of $43.75, suggesting a potential upside of 84.48%. Given Electromed’s higher possible upside, equities analysts plainly believe Electromed is more favorable than Jushi.
Summary
Electromed beats Jushi on 11 of the 14 factors compared between the two stocks.
About Electromed
Electromed, Inc. develops, manufactures and markets airway clearance products for people who have difficulty clearing mucus from their lungs. Its products use high-frequency chest wall oscillation, a therapy that applies gentle vibrations to the chest to help loosen and move airway secretions. The company’s main product line is the SmartVest Airway Clearance System, which includes wearable vests and related equipment. These systems are used in managing conditions associated with impaired mucus clearance, including bronchiectasis, cystic fibrosis and certain neuromuscular disorders.
About Jushi
Jushi Holdings Inc. is a U.S. cannabis company focused on cultivating, processing and selling cannabis products. Its business includes cultivation and manufacturing facilities as well as retail dispensaries serving medical and adult-use customers in markets where cannabis sales are permitted. The company’s product portfolio has included flower, concentrates, vapes and other cannabis products sold under brands such as The Bank, The Lab and Sèchè. Its retail operations have included the Beyond Hello dispensary brand.
Receive News & Ratings for Electromed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed and related companies with MarketBeat.com's FREE daily email newsletter.
